{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T00:31:08Z","timestamp":1760056268897,"version":"build-2065373602"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100007594","name":"Univerzita Komensk\u00e9ho v Bratislave","doi-asserted-by":"publisher","award":["UK\/321\/2017"],"award-info":[{"award-number":["UK\/321\/2017"]}],"id":[{"id":"10.13039\/100007594","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001823","name":"Ministerstvo \u0160kolstv\u00ed, Ml\u00e1de\u017ee a T\u011blov\u00fdchovy","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001823","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005357","name":"Agent\u00fara na Podporu V\u00fdskumu a V\u00fdvoja","doi-asserted-by":"publisher","award":["APVV-0052-12","APVV-16-0124"],"award-info":[{"award-number":["APVV-0052-12","APVV-16-0124"]}],"id":[{"id":"10.13039\/501100005357","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006109","name":"Vedeck\u00e1 Grantov\u00e1 Agent\u00fara M\u0160VVa\u0160 SR a SAV","doi-asserted-by":"publisher","award":["2\/005019"],"award-info":[{"award-number":["2\/005019"]}],"id":[{"id":"10.13039\/501100006109","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.jpba.2021.114168","type":"journal-article","created":{"date-parts":[[2021,5,24]],"date-time":"2021-05-24T12:23:33Z","timestamp":1621859013000},"page":"114168","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Development of LC-HRMS methods for evaluation of metabolic conversion of 5-fluorocytosine at GDEPT procedure"],"prefix":"10.1016","volume":"203","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3022-7404","authenticated-orcid":false,"given":"Pavel","family":"Skvara","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erika","family":"Durinikova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6026-6260","authenticated-orcid":false,"given":"Kate\u0159ina","family":"Grabicov\u00e1","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erika","family":"Mordacikova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0747-9275","authenticated-orcid":false,"given":"Miroslava","family":"Matuskova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8541-5170","authenticated-orcid":false,"given":"Andrea","family":"Vojs Stanova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpba.2021.114168_bib0005","series-title":"All cancers, Globocan 2018","first-page":"1","author":"International Agency for Research on Cancer","year":"2019"},{"year":"2015","series-title":"International Agency for Research on Cancer - the First 50 (1965-2015) Years","author":"Saracci","key":"10.1016\/j.jpba.2021.114168_bib0010"},{"key":"10.1016\/j.jpba.2021.114168_bib0015","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1007\/s00216-010-3633-8","article-title":"A review of analytical methods for the determination of 5-fluorouracil in biological matrices","volume":"397","author":"Breda","year":"2010","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.jpba.2021.114168_bib0020","doi-asserted-by":"crossref","first-page":"251","DOI":"10.2217\/pgs.10.167","article-title":"5-Fluorouracil pharmacogenomics: Still rocking after all these years?","volume":"12","author":"Scartozzi","year":"2011","journal-title":"Pharmacogenomics."},{"key":"10.1016\/j.jpba.2021.114168_bib0025","first-page":"6193","article-title":"Fluctuation in plasma 5-fluorouracil concentration during continuous 5-fluorouracil infusion for colorectal cancer","volume":"35","author":"Matsumoto","year":"2015","journal-title":"Anticancer Res."},{"key":"10.1016\/j.jpba.2021.114168_bib0030","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1200\/JCO.2002.20.6.1683","article-title":"Comparative pharmacokinetic study of continuous venous infusion fluorouracil and oral fluorouracil with eniluracil in patients with advanced solid tumors","volume":"20","author":"Adjei","year":"2002","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.jpba.2021.114168_bib0035","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1128\/AAC.01103-09","article-title":"Clinical pharmacokinetics of oral controlled-release 5-fluorocytosine","volume":"54","author":"Pai","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.jpba.2021.114168_bib0040","first-page":"1322","article-title":"Colorectal tumors responding to 5-fluorouracil have low gene expression levels of dihydropyrimidine dehydrogenase, thymidylate synthase, and thymidine phosphorylase","volume":"6","author":"Salonga","year":"2000","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jpba.2021.114168_bib0045","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.jconrel.2015.01.003","article-title":"Genetically engineered theranostic mesenchymal stem cells for the evaluation of the anticancer efficacy of enzyme\/prodrug systems","volume":"200","author":"Nouri","year":"2015","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jpba.2021.114168_bib0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.canlet.2017.08.016","article-title":"Targeted antitumor therapy mediated by prodrug-activating mesenchymal stromal cells","volume":"408","author":"Kucerova","year":"2017","journal-title":"Cancer Lett."},{"key":"10.1016\/j.jpba.2021.114168_bib0055","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1208\/s12248-014-9675-7","article-title":"Gene-directed enzyme prodrug therapy","volume":"17","author":"Zhang","year":"2015","journal-title":"AAPS J."},{"key":"10.1016\/j.jpba.2021.114168_bib0060","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1093\/jac\/46.2.171","article-title":"Flucytosine: a review of its pharmacology, clinical indications, pharmacokinetics, toxicity and drug interactions","volume":"46","author":"Vermes","year":"2000","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.jpba.2021.114168_bib0065","first-page":"1503","article-title":"Tumors expressing the cytosine deaminase suicide gene can Be eliminated in vivo with 5-Fluorocytosine and induce protective immunity to wild type tumor","volume":"54","author":"Mullen","year":"1994","journal-title":"Cancer Res."},{"key":"10.1016\/j.jpba.2021.114168_bib0070","first-page":"4619","article-title":"In vivo antitumor activity of 5-Fluorocytosine on human colorectal carcinoma cells genetically modified to express cytosine deaminase","volume":"53","author":"Huber","year":"1993","journal-title":"Cancer Res."},{"key":"10.1016\/j.jpba.2021.114168_bib0075","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/s41417-018-0030-5","article-title":"Cytotoxic response of 5-fluorouracil-resistant cells to gene- and cell-directed enzyme\/prodrug treatment","volume":"25","author":"Durinikova","year":"2018","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.jpba.2021.114168_bib0080","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1038\/sj.bjc.6601345","article-title":"Non-invasive 19 F MR spectroscopy of 5-fluorocytosine to 5-fluorouracil conversion by recombinant Salmonella in tumours","volume":"89","author":"Dresselaers","year":"2003","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.jpba.2021.114168_bib0085","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.jpba.2005.01.047","article-title":"Fluorine-19 or phosphorus-31 NMR spectroscopy: A suitable analytical technique for quantitative in vitro metabolic studies of fluorinated or phosphorylated drugs","volume":"38","author":"Martino","year":"2005","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2021.114168_bib0090","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.talanta.2013.04.070","article-title":"Multianalyte determination of 24 cytostatics and metabolites by liquid chromatography-electrospray-tandem mass spectrometry and study of their stability and optimum storage conditions in aqueous solution","volume":"116","author":"Negreira","year":"2013","journal-title":"Talanta"},{"key":"10.1016\/j.jpba.2021.114168_bib0095","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1002\/bmc.1326","article-title":"Development and validation of a rapid and sensitive HPLC method for the quantification of 5-fluorocytosine and its metabolites","volume":"24","author":"Serve","year":"2010","journal-title":"Biomed. Chromatogr."},{"key":"10.1016\/j.jpba.2021.114168_bib0100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jchromb.2018.01.011","article-title":"Simultaneous detection of 5-fluorocytosine and 5-fluorouracil in human cells carrying CD\/5-FC suicide gene system by using capillary zone electrophoresis","volume":"1076","author":"Liu","year":"2018","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.jpba.2021.114168_bib0105","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1002\/jgm.2684","article-title":"Intrinsic properties of tumour cells have a key impact on the bystander effect mediated by genetically engineered mesenchymal stromal cells","volume":"14","author":"Matuskova","year":"2012","journal-title":"J. Gene Med."},{"key":"10.1016\/j.jpba.2021.114168_bib0110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12885-018-4758-y","article-title":"ALDH1A3 upregulation and spontaneous metastasis formation is associated with acquired chemoresistance in colorectal cancer cells","volume":"18","author":"Durinikova","year":"2018","journal-title":"BMC Cancer"},{"key":"10.1016\/j.jpba.2021.114168_bib0115","doi-asserted-by":"crossref","first-page":"6304","DOI":"10.1158\/0008-5472.CAN-06-4024","article-title":"Adipose tissue-derived human mesenchymal stem cells mediated prodrug cancer gene therapy","volume":"67","author":"Kucerova","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.jpba.2021.114168_bib0120","first-page":"342","article-title":"Treatment of rat gliomas with recombinant retrovirus harboring Herpes simplex virus thymidine kinase suicide gene","volume":"44","author":"Hlavat\u00fd","year":"1997","journal-title":"Neoplasma."},{"key":"10.1016\/j.jpba.2021.114168_bib0125","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.canlet.2009.08.028","article-title":"HSV-tk expressing mesenchymal stem cells exert bystander effect on human glioblastoma cells","volume":"290","author":"Matuskova","year":"2010","journal-title":"Cancer Lett."},{"key":"10.1016\/j.jpba.2021.114168_bib0130","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.aca.2015.02.017","article-title":"Tutorial review on validation of liquid chromatography-mass spectrometry methods: part I","volume":"870","author":"Kruve","year":"2015","journal-title":"Anal. Chim. Acta"},{"key":"10.1016\/j.jpba.2021.114168_bib0135","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.aca.2015.02.016","article-title":"Tutorial review on validation of liquid chromatography-mass spectrometry methods: part II","volume":"870","author":"Kruve","year":"2015","journal-title":"Anal. Chim. Acta"},{"key":"10.1016\/j.jpba.2021.114168_bib0140","doi-asserted-by":"crossref","first-page":"3019","DOI":"10.1021\/ac020361s","article-title":"Strategies for the assessment of matrix effect in quantitative bioanalytical methods based on HPLC-MS\/MS","volume":"75","author":"Matuszewski","year":"2003","journal-title":"Anal. Chem."},{"key":"10.1016\/j.jpba.2021.114168_bib0145","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1080\/10826076.2010.503842","article-title":"A liquid chromatography-mass spectrometry method for the simultaneous determination of capecitabine, 5\u2019deoxy-5-fluorocytidine, 5\u2019-deoxy-5-fluorouridine, 5-fluorouracil, and 5-fluorodihydrouracil in human plasma","volume":"33","author":"Svobaite","year":"2010","journal-title":"J. Liq. Chromatogr. Relat. Technol."},{"key":"10.1016\/j.jpba.2021.114168_bib0150","first-page":"1419","article-title":"Thymidylate synthase gene amplification in human colon cancer cell lines resistant to 5-fluorouracil","volume":"49","author":"Copur","year":"1995","journal-title":"Arch. Argent. Pediatr."},{"key":"10.1016\/j.jpba.2021.114168_bib0155","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/nrc1074","article-title":"5-Fluorouracil: mechanisms of action and clinical strategies","volume":"3","author":"Longley","year":"2003","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.jpba.2021.114168_bib0160","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1158\/1535-7163.MCT-08-0219","article-title":"Thymidylate synthase gene variations: predictive and prognostic markers","volume":"8","author":"Lurje","year":"2009","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.jpba.2021.114168_bib0165","doi-asserted-by":"crossref","first-page":"3201","DOI":"10.1016\/j.chroma.2009.09.052","article-title":"Porous graphitic carbon: a versatile stationary phase for liquid chromatography","volume":"1217","author":"West","year":"2010","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.jpba.2021.114168_bib0170","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1002\/bmc.3743","article-title":"A simultaneous determination method for 5-fluorouracil and its metabolites in human plasma with linear range adjusted by in-source collision-induced dissociation using hydrophilic interaction liquid chromatography-electrospray ionization-tandem mass spect","volume":"30","author":"Ishii","year":"2016","journal-title":"Biomed. Chromatogr."},{"key":"10.1016\/j.jpba.2021.114168_bib0175","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/s41417-018-0030-5","article-title":"Cytotoxic response of 5-fluorouracil-resistant cells to gene- and cell-directed enzyme\/prodrug treatment","volume":"25","author":"Durinikova","year":"2018","journal-title":"Cancer Gene Ther."}],"container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S073170852100279X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S073170852100279X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T09:13:31Z","timestamp":1760001211000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S073170852100279X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":35,"alternative-id":["S073170852100279X"],"URL":"https:\/\/doi.org\/10.1016\/j.jpba.2021.114168","relation":{},"ISSN":["0731-7085"],"issn-type":[{"type":"print","value":"0731-7085"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development of LC-HRMS methods for evaluation of metabolic conversion of 5-fluorocytosine at GDEPT procedure","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical and Biomedical Analysis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpba.2021.114168","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"114168"}}